Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Symphony Environmental Technologies Plc LSE:SYM London Ordinary Share GB0009589168 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 28.00 27.00 29.00 28.00 27.50 28.00 205,325 16:18:28
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 8.2 -0.7 -0.4 - 49

Symphony Environmental Tech. PLC Result of AGM & Update on Antiviral Testing

26/06/2020 1:13pm

UK Regulatory (RNS & others)


Symphony Environmental T... (LSE:SYM)
Historical Stock Chart


From Jun 2020 to Sep 2020

Click Here for more Symphony Environmental T... Charts.

TIDMSYM

RNS Number : 2579R

Symphony Environmental Tech. PLC

26 June 2020

 
    26 June 2020 
 
 

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

(the "Company")

Result of Annual General Meeting and update on antiviral testing

Symphony Environmental Technologies plc (AIM: SYM) announces that all resolutions were duly passed at the Company's Annual General Meeting ("AGM") held today.

A summary of the votes lodged by proxy at the AGM is set out below:

 
 Resolution                   In Favour            Against          Number   Total votes 
                                                                  of votes          cast 
                                                                  withheld 
                              Number       %   Number of     % 
                            of votes               votes 
                         -----------  ------  ----------  ---- 
      Annual report 
       and accounts 
       for FY19 are 
       received and 
 1     adopted            24,265,203   100.0           0   0.0      20,000    24,285,203 
     ------------------  -----------  ------  ----------  ----  ----------  ------------ 
      Michael Laurier 
       re-election 
 2     as a Director      24,262,025    99.9      20,000   0.1       3,178    24,285,203 
     ------------------  -----------  ------  ----------  ----  ----------  ------------ 
      Robert Wigley 
       re-election 
 3     as a Director      24,249,525    99.9      32,500   0.1       3,178    24,285,203 
     ------------------  -----------  ------  ----------  ----  ----------  ------------ 
      Re-appointment 
       of Mazars LLP 
       as the Company's 
 4     auditors           24,259,691   100.0       2,334   0.0      23,178    24,285,203 
     ------------------  -----------  ------  ----------  ----  ----------  ------------ 
      Authority to 
       allot securities 
       per section 
       551 of the 
       Companies Act 
 5     2006               24,262,025    99.9      20,000   0.1       3,178    24,285,203 
     ------------------  -----------  ------  ----------  ----  ----------  ------------ 
      Authority to 
       allot securities 
       otherwise than 
       on a pre-emptive 
 6*    basis              24,198,825    99.7      83,200   0.3       3,178    24,285,203 
     ------------------  -----------  ------  ----------  ----  ----------  ------------ 
      Authority to 
       purchase the 
       Company's own 
 7*    ordinary shares    24,198,825    99.7      83,200   0.2       3,178    24,285,203 
     ------------------  -----------  ------  ----------  ----  ----------  ------------ 
 

* Special Resolution

Notes

   --      A vote withheld is not a vote in law and does not count in the total of votes cast. 

-- Any proxy appointments which gave discretion to the chairman of the meeting have been included in the "for" total.

-- The issued share capital of the Company eligible to vote on resolutions was 154,569,377 Ordinary Shares of 1p each.

In light of the Coronavirus pandemic and the social distancing measures in place, shareholders were not be able to attend the AGM in person. The Company will continue to update shareholders in the usual way, via the Regulatory News System (RNS).

Update on antiviral testing

Further to the Company's preliminary results announcement on 26 May 2020, antiviral testing continues and we now expect the results of these during quarter three rather than 30 June 2020 as previously indicated.

Enquiries

 
 Symphony Environmental Technologies Plc 
 Michael Laurier, CEO                          Tel: +44 (0) 20 8207 
                                                5900 
 Ian Bristow, CFO 
 www.symphonyenvironmental.com 
 
 Cantor Fitzgerald Europe (Nominated Adviser 
  and Joint Broker) 
 David Foreman (Corporate Finance)             Tel: +44 (0) 20 7894 
                                                7000 
 
 Hybridan LLP (Joint Broker)                    Tel: +44 (0) 203 
  Claire Louise Noyce                            764 2341 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGSEFFEMESSEFM

(END) Dow Jones Newswires

June 26, 2020 08:13 ET (12:13 GMT)

1 Year Symphony Environmental T... Chart

1 Year Symphony Environmental T... Chart

1 Month Symphony Environmental T... Chart

1 Month Symphony Environmental T... Chart
ADVFN Advertorial
Your Recent History
LSE
SYM
Symphony E..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200925 23:25:44